The relevance of the 5HT2A–mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin
Revista de Neuro-Psiquiatría · 30.06.2026 · 89 (2) · 245-246
DOI: 10.20453/rnp.v89i2.7539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista de Neuro-Psiquiatría, online erschienen am 30.06.2026. Verfasst von Guillermo Escobar-Cornejo und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Escobar-Cornejo, G., Corredor-Gamba, J., Rodriguez-Rojas, Y., & Cárdenas, F. P. (2026). The relevance of the 5HT2A–mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin. Revista de Neuro-Psiquiatría, 89(2), 245-246. https://doi.org/10.20453/rnp.v89i2.7539
Vancouver
Escobar-Cornejo G, Corredor-Gamba J, Rodriguez-Rojas Y, Cárdenas FP. The relevance of the 5HT2A–mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin. Revista de Neuro-Psiquiatría. 2026;89(2):245-246. doi:10.20453/rnp.v89i2.7539
BibTeX
@article{EscobarCornejo2026,
author = {Escobar-Cornejo, Guillermo and Corredor-Gamba, Julián and Rodriguez-Rojas, Yoly and Cárdenas, F. P.},
title = {The relevance of the 5HT2A–mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin},
journal = {Revista de Neuro-Psiquiatría},
year = {2026},
volume = {89},
number = {2},
pages = {245--246},
doi = {10.20453/rnp.v89i2.7539}
}
EUVIMED